The fluctuation of nocturia in men with lower urinary tract symptoms allocated to placebo during a 12-month randomized, controlled trial

Journal of Urology

Volumn 191, Issue 4, 2014, Pages 1040-1044

  Vaughan, Camille P ^a,b   Johnson II, Theodore M ^a,b   Haukka, Jari ^d   Cartwright, Rufus ^f   Howard, Marion E ^c   Jones, Karen M ^a   Markland, Alayne D ^a,g   Goode, Patricia S ^a,g   Burgio, Kathryn L ^a,g   Tikkinen, Kari A O ^e,h  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f ST MARY S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^h MCMASTER UNIVERSITY   (Canada)

Author keywords

lower urinary tract symptoms; nocturia; prostate; prostatic hyperplasia; United States Department of Veterans Affairs

Indexed keywords

FINASTERIDE; PLACEBO; TERAZOSIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; URINARY FREQUENCY; URINE FLOW RATE; DISEASE COURSE; POST HOC ANALYSIS; POSTVOID RESIDUAL URINE VOLUME; PROSTATE HYPERTROPHY; PROSTATE SIZE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

LOWER URINARY TRACT SYMPTOMS; NOCTURIA; PROSTATE; PROSTATIC HYPERPLASIA; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

AGED; AGED, 80 AND OVER; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; NOCTURIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 84898432477     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.11.105     Document Type: Article

References (17)

1. P. van Kerrebroeck, P. Abrams, and D. Chaikin et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 179
2. C.E. DuBeau, S.V. Yalla, and N.M. Resnick Implications of the most bothersome prostatism symptom for clinical care and outcomes research J Am Geriatr Soc 43 1995 985
3. K.A.O. Tikkinen, T.M. Johnson II, and T.L.J. Tammela et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland Eur Urol 57 2010 488
4. J.P. Weiss, A.J. Wein, and P. van Kerrebroeck et al. Nocturia: new directions Neurourol Urodyn 30 2011 700
5. J.T. Häkkinen, M. Hakama, and R. Shiri et al. Incidence of nocturia in 50 to 80-year-old Finnish men J Urol 176 2006 2541
6. U.G.H. Malmsten, U. Molander, and R. Peeker et al. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years Eur Urol 58 2010 149
7. F. Fukuta, N. Masumori, and M. Mori et al. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study BJU Int 110 2012 1023
8. T.M. Johnson 2nd, R.W. Sattin, and P. Parmelee et al. Evaluating potentially modifiable risk factors for prevalent and incident nocturia in older adults J Am Geriatr Soc 53 2005 1011
9. B. van Doorn, M.H. Blanker, and E.T. Kok et al. Once nocturia, always nocturia? Natural history of nocturia in older men based on frequency-volume charts: the Krimpen Study J Urol 186 2011 1956
10. J. Pekkanen, J. Sunyer, and S. Chinn Nondifferential disease misclassification may bias incidence risk ratios away from the null J Clin Epidemiol 59 2006 281
11. V. Kupelian, J.T. Wei, and M.P. O'Leary et al. Nocturia and quality of life: results from the Boston Area Community Health survey Eur Urol 61 2012 78
12. M. Oelke, A. Bachmann, and A. Descazeaud et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction Eur Urol 64 2013 118
13. H. Lepor, W.O. Williford, and M.J. Barry et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group N Engl J Med 335 1996 533
14. M.J. Barry, F.J. Fowler Jr., and M.P. O'Leary et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549
15. Bates D, Maechler M and Bolker B: Linear mixed-effects models using S4 classes. R package, version 0.999999-0, 2012. Available at http://CRAN.R- project.org/package=lme4. Accessed November 13, 2013.
16. K.M.C. Verhamme, J.P. Dieleman, and G.S. Bleumink et al. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project Eur Urol 44 2003 539
17. J.M. Bland, and D.G. Altman Some examples of regression towards the mean BMJ 309 1994 780